Cocrystal Pharma appoints Fred Hassan to board; he invests $2M in company

Cocrystal Pharma, Inc.

Fred Hassan appointed to Board of Directors on April 20, 2023, increasing board to six members.
Hassan invested $2 million in Cocrystal, purchasing 1,015,229 shares alongside director Phillip Frost.
Hassan brings 40-year pharma industry experience, having served as CEO of Schering-Plough and Pharmacia.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Fred Hassan

director

COCP · Cocrystal Pharma, Inc.

Effective: 2023-04-20
Filed: April 24, 2023, 7:59 PM ET

On April 20, 2023, the Board of Directors of Cocrystal Pharma, Inc. (the “Company”) appointed Fred Hassan as a director, thereby increasing the number of directors to six.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Fred Hassan was appointed as director at Cocrystal Pharma, Inc..

Action: appointed
Role: director

Exact text from the filing

On April 20, 2023, the Board of Directors of Cocrystal Pharma, Inc. (the “Company”) appointed Fred Hassan as a director, thereby increasing the number of directors to six.

View on SEC.gov

Cocrystal Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-013321

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.